FDA Adverse Event Injury Summary report: N

THERASPHERE 20 GBQ

MDR report key: 319770 · Received March 6, 2001

Report

Report Number
8022247-2001-00002
Event Type
Injury
Date Received
March 6, 2001
Date of Event
September 20, 2000
Report Date
March 1, 2001
Manufacturer
MDS NORDION, INC.
Product Code
KXK
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

PT WAS ADMITTED 09-00 FOR ABDOMINAL PAIN, NAUSEA AND ANOREXIA. PT HAS HAD INTERMITTENT ABDOMINAL PAIN SINCE THEIR THERASPHERE TREATMENT. PT HAS NO HISTORY OF ULCER DISEASE. PHYSICAL EXAM SHOWED EPIGASTRIC AND RIGHT UPPER QUADRANT TENDERNESS. PT WAS TREATED WITH IV FLUIDS, IV MORPHINE (09-20-00) AND IV ZANTAC. AN ABDOMINAL CT-SCAN SHOWED NO CHANGE FROM THE PREVIOUS CT-SCAN. THE PAIN RESOLVED, AND THE PT WAS DISCHARGED THE FOLLOWING DAY ON MORPHINE SOLUTION AS NEEDED AND AXID.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
9454 THERASPHERE 20 GBQ RADIOACTIVE GLASS MICROSPHERES KXK MDS NORDION, INC. * 990004

Patients

Seq Age Sex Outcome Treatment
1 69 YR Hospitalization